v3.20.4
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Operating expenses:      
Research and development $ 30,981 $ 27,363 $ 18,136
General and administrative 11,969 9,979 6,590
Total operating expenses 42,950 37,342 24,726
Loss from operations (42,950) (37,342) (24,726)
Interest income 1,208 2,255 1,559
Net loss $ (41,742) $ (35,087) $ (23,167)
Net loss per common share, basic and diluted $ (0.95) $ (1.84) $ (2.26)
Weighted-average shares used to compute net loss per common share, basic and diluted 44,004,190 19,083,826 10,264,584

Source